Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma.

Guevara-Canales JO, Morales-Vadillo R, Cava-Vergiú CE, Leite FP, Miranda Chaves Netto HD, Soares FA, Chaves Md.

Braz Oral Res. 2013 Jul-Aug;27(4):349-55. doi: 10.1590/S1806-83242013005000018. Epub 2013 Jun 11.

2.

Malignant lymphoma of the oral cavity and the maxillofacial region: overall survival prognostic factors.

Guevara-Canales JO, Morales-Vadillo R, Sacsaquispe-Contreras SJ, Barrionuevo-Cornejo C, Montes-Gil J, Cava-Vergiú CE, Soares FA, Chaves-Netto HD, Chaves MD.

Med Oral Patol Oral Cir Bucal. 2013 Jul 1;18(4):e619-26.

3.

Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.

Abdelhamid T, Samra M, Ramadan H, Mehessin M, Mokhtar N.

J Egypt Natl Canc Inst. 2011 Mar;23(1):17-24. doi: 10.1016/j.jnci.2011.07.003. Epub 2011 Sep 8.

5.

Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.

Kolokotronis A, Konstantinou N, Christakis I, Papadimitriou P, Matiakis A, Zaraboukas T, Antoniades D.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Mar;99(3):303-10.

PMID:
15716836
6.

Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature.

Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Gkagkalis A.

J Oral Maxillofac Surg. 2012 Dec;70(12):2776-85. doi: 10.1016/j.joms.2012.01.018. Epub 2012 Apr 10.

PMID:
22494508
7.

[Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases].

Yang YL, Wang J, Zhao LZ, Gao ZF, Jing HM, Ke XY.

Ai Zheng. 2008 Jun;27(6):636-41. Chinese.

PMID:
18570740
8.

Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.

Morabito F, Gallamini A, Stelitano C, Callea V, Guglielmi C, Neri S, Lazzaro A, Orsucci L, Ilariucci F, Sacchi S, Vitolo U, Federico M.

Cancer. 2004 Oct 1;101(7):1601-8.

9.

Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.

Nicolaides C, Fountzilas G, Zoumbos N, Skarlos D, Kosmidis P, Pectasides D, Karabelis A, Giannakakis T, Symeonidis A, Papadopoulos A, Antoniou F, Pavlidis N.

Oncology. 1998 Sep-Oct;55(5):405-15.

PMID:
9732217
10.

A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.

Li X, Xia B, Guo S, Zhan Z, Zhang L, Zhao D, Wu X, Zhang Y.

Ann Hematol. 2013 Jun;92(6):807-15. doi: 10.1007/s00277-013-1701-9. Epub 2013 Feb 17.

PMID:
23417758
11.
12.

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.

Villa D, Connors JM, Sehn LH, Gascoyne RD, Savage KJ.

Haematologica. 2011 Jul;96(7):1002-7. doi: 10.3324/haematol.2011.041277. Epub 2011 Apr 12.

13.

Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.

Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y, Morishima Y.

Eur J Haematol. 2008 Dec;81(6):448-53. doi: 10.1111/j.1600-0609.2008.01129.x. Epub 2008 Aug 6.

PMID:
18691256
14.

Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.

Larouche JF, Berger F, Chassagne-Clément C, Ffrench M, Callet-Bauchu E, Sebban C, Ghesquières H, Broussais-Guillaumot F, Salles G, Coiffier B.

J Clin Oncol. 2010 Apr 20;28(12):2094-100. doi: 10.1200/JCO.2009.24.5860. Epub 2010 Mar 22.

PMID:
20308668
15.

[Clinical characteristics and prognosis of diffuse large B-cell lymphoma].

Yang BY, Yong WB, Zhu J, Zheng W, Zhang YT, Wang XP, Meng SN.

Zhonghua Zhong Liu Za Zhi. 2005 Mar;27(3):174-6. Chinese.

PMID:
15946571
16.

Prognosis of localized diffuse large B-cell lymphoma in younger patients.

Møller MB, Christensen BE, Pedersen NT.

Cancer. 2003 Aug 1;98(3):516-21.

17.

Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma.

Cox MC, Nofroni I, Ruco L, Amodeo R, Ferrari A, La Verde G, Cardelli P, Montefusco E, Conte E, Monarca B, Aloe-Spiriti MA.

Leuk Lymphoma. 2008 Sep;49(9):1745-51. doi: 10.1080/10428190802226425.

PMID:
18798109
18.

Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?

Laskar S, Bahl G, Muckaden MA, Nair R, Gupta S, Bakshi A, Gujral S, Shet T, Shrivastava SK, Dinshaw KA.

Cancer. 2007 Aug 15;110(4):816-23.

19.

EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru.

Beltran BE, Castillo JJ, Morales D, de Mendoza FH, Quinones P, Miranda RN, Gallo A, Lopez-Ilasaca M, Butera JN, Sotomayor EM.

Am J Hematol. 2011 Aug;86(8):663-7. doi: 10.1002/ajh.22078.

20.

Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study.

Rasmussen PK, Ralfkiaer E, Prause JU, Sjö LD, Toft PB, Siersma VD, Heegaard S.

Acta Ophthalmol. 2013 Mar;91(2):163-9. doi: 10.1111/j.1755-3768.2011.02337.x. Epub 2012 May 2.

Supplemental Content

Support Center